InChI=1S/C44H56O8/c1-39(2)22-23-44(38(49)50)21-18-32-41(5)19-16-31-40(3,4)35(52-37(48)27-10-14-29(46)15-11-27)30(51-36(47)26-8-12-28(45)13-9-26)24-43(31,7)33(41)17-20-42(32,6)34(44)25-39/h8-15,18,30-31,33-35,45-46H,16-17,19-25H2,1-7H3,(H,49,50)/t30-,31+,33+,34+,35+,41+,42-,43+,44-/m1/s1 |
XPEVLOSUULAUFH-AHHVVZNJSA-N |
[H][C@@]12CC[C@@]3(C)C4=CC[C@]5(CCC(C)(C)C[C@@]5([H])[C@]4(C)CC[C@]3([H])[C@@]1(C)C[C@@H](OC(=O)c1ccc(O)cc1)[C@H](OC(=O)c1ccc(O)cc1)C2(C)C)C(O)=O |
|
Maprounea africana
(IPNI:352049-1)
|
See:
PubMed
|
HIV-1 reverse transcriptase inhibitor
An entity which inhibits the activity of HIV-1 reverse transcriptase.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
Outgoing
|
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
has functional parent
4-hydroxybenzoic acid
(CHEBI:30763)
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
has functional parent
maprounic acid
(CHEBI:73107)
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
has role
HIV-1 reverse transcriptase inhibitor
(CHEBI:53756)
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
has role
metabolite
(CHEBI:25212)
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
is a
benzoate ester
(CHEBI:36054)
2α-hydroxymaprounic acid 2,3-bis-p-hydroxybenzoate
(CHEBI:66672)
is a
pentacyclic triterpenoid
(CHEBI:25872)
|
|
(4aS,6bR,8aR,10R,11R,12aR,12bR,14aS,14bS)-10,11-bis[(4-hydroxybenzoyl)oxy]-2,2,6b,9,9,12a,14a-heptamethyl-1,3,4,5,6b,7,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-octadecahydropicene-4a(2H)-carboxylic acid
|
D-Friedoolean-14-en-28-oic acid, 1,3-bis((4-hydroxybenzoyl)oxy)-,(1beta,3beta)-
|
ChemIDplus
|
155510-78-4
|
CAS Registry Number
|
ChemIDplus
|
7515410
|
PubMed citation
|
Europe PMC
|
|